
|Articles|March 28, 2022
Pill Connect Releases New Adherence Data
Advertisement
Pill Connect has announced the availability of patient adherence data to support the launch of its Smart Dispenser technology.
In a recent usability study conducted in partnership with major pharma, Smart Dispenser successfully demonstrated dispensing and monitoring at an individual pill-level in real-time without any data upload activity required by the participant. It also highlighted some user acceptance improvements that have been captured in the modified design.
Read more about Pill Connect and its Smart Dispenser technology
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
3
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
4
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
5




